Logo image of GYRE

GYRE THERAPEUTICS INC (GYRE) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:GYRE - US4037831033 - Common Stock

8.03 USD
-0.06 (-0.74%)
Last: 1/28/2026, 8:00:01 PM
8.03 USD
0 (0%)
After Hours: 1/28/2026, 8:00:01 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to GYRE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 18.36. This target is 128.64% above the current price.
  • GYRE was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about GYRE.
  • In the previous month the buy percentage consensus was at a similar level.
  • GYRE was analyzed by 9 analysts. More opinions would make the average more meaningful.
GYRE Historical Analyst RatingsGYRE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -36 -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 8.0316.1618.3618.3621.00 - 101.25% 128.64% 128.64% 161.52%
GYRE Current Analyst RatingGYRE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-10-10 Jefferies Initiate Buy
2025-08-26 HC Wainwright & Co. Initiate Buy

GYRE THERAPEUTICS INC / GYRE FAQ

What is the price target for GYRE stock?

9 analysts have analysed GYRE and the average price target is 18.36 USD. This implies a price increase of 128.64% is expected in the next year compared to the current price of 8.03.


How do analysts rate GYRE THERAPEUTICS INC (GYRE)?

The consensus rating for GYRE THERAPEUTICS INC (GYRE) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for GYRE stock?

The number of analysts covering GYRE THERAPEUTICS INC (GYRE) is 9.